Researchers have developed an AI model that can predict where a drug molecule can be chemically altered.
Biogen ALS drug gets FDA ok
The U.S. Food and Drug Administration (FDA) has approved Biogen’s QALSODY (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis (ALS) in adults
April 27, 2023